Immune Thrombocytopenic Purpura (ITP)

USMLE Step 1 trap: Incorrectly selects platelet transfusion as early therapy in ITP, where transfused platelets are rapidly destroyed. Platelet transfusion is not first-line in ITP because transfused platelets are rapidly destroyed by the same anti-GPIIb/IIIa antibodies; it is reserved for life-threatening bleeding.

Immune Thrombocytopenic Purpura (ITP) is an autoimmune condition where IgG antibodies target GPIIb/IIIa on platelet surfaces, leading to splenic macrophage-mediated destruction and isolated thrombocytopenia. USMLE Step 1 tests ITP from multiple angles — and the reflexive wrong answer is transfusing platelets. Anti-GPIIb/IIIa antibodies will destroy transfused platelets just as efficiently as native ones, often within minutes to hours, so platelet transfusion provides no durable benefit and is reserved only for life-threatening hemorrhage. The coagulation cascade is entirely intact in ITP, which is the key feature that distinguishes it from DIC and TTP, and that distinction is exactly where the exam sets its traps.

The exam loves to disguise ITP in vignettes — a child with petechiae after a URI, an adult woman with easy bruising and a platelet count of 20,000, or an HIV-positive patient with thrombocytopenia. The trick is always the same: isolated low platelets with normal PT, PTT, and fibrinogen. If you see elevated coag studies, think DIC or TTP, not ITP. Students frequently conflate these disorders because they all cause low platelets, but the mechanism and lab pattern are completely different.

Management is the other major trap. USMLE Step 1 rewards students who know that platelet transfusion is not first-line — transfused platelets get chewed up by the same antibodies just as fast as native ones. First-line is steroids (± IVIG for rapid response). The pediatric vs adult distinction also shows up: kids usually get a self-limited post-viral course that may not need treatment, while adults trend chronic and require stepwise immunosuppression. Know both paths cold.

From real student decks

76%have cards covering this topic

65%have mature cards

1.0median lapses in 14 days

Common misconceptions

Common mistake

Wrong: Platelet transfusion should be given early in ITP to correct the low platelet count.

Right: Platelet transfusion is not first-line in ITP because transfused platelets are rapidly destroyed by the same anti-GPIIb/IIIa antibodies; it is reserved for life-threatening bleeding.

Transfusing platelets in ITP feels intuitive — the count is low, so replace them. But the anti-GPIIb/IIIa antibodies circulating in the patient's blood will coat and destroy transfused platelets just as efficiently as native ones, often within minutes to hours. Platelet transfusion provides no durable benefit and is reserved only for life-threatening hemorrhage where even a brief bump in count matters; first-line treatment is directed at suppressing antibody production and Fc-receptor blockade with steroids and IVIG.

Common mistake

Wrong: ITP causes elevated PT and PTT in addition to thrombocytopenia.

Right: ITP causes isolated thrombocytopenia with normal PT, PTT, and fibrinogen because only platelet destruction occurs, not coagulation factor consumption.

ITP is purely a platelet destruction problem — the coagulation cascade is completely untouched. There is no factor consumption, no fibrinogen breakdown, and no thrombin generation abnormality. If you see elevated PT or PTT alongside thrombocytopenia, you should immediately think DIC (factor consumption) or TTP (ADAMTS13 deficiency), not ITP. Locking in 'normal PT, PTT, fibrinogen' as the ITP signature prevents you from confusing these conditions on the exam.

Common mistake

Gap: Missing HIV and hepatitis C as secondary causes of ITP that must be excluded in the workup

HIV and hepatitis C are important secondary causes of ITP that must be excluded before diagnosing primary ITP, as treatment of the underlying infection may resolve thrombocytopenia.

HIV and hepatitis C both cause immune dysregulation that can produce anti-platelet antibodies and result in a picture indistinguishable from primary ITP on CBC alone. This matters clinically and for USMLE Step 1 because treating the primary ITP with steroids alone may worsen the underlying infection, and treating the infection itself can resolve the thrombocytopenia. Any thrombocytopenia workup should include HIV and HCV testing before the diagnosis of primary ITP is finalized.

Common mistake

Wrong: Pediatric and adult ITP have the same natural history and require the same management approach.

Right: Pediatric ITP is usually self-limited and follows viral illness, often resolving without treatment; adult ITP is more often chronic and requires stepwise immunosuppressive therapy.

Pediatric ITP is typically triggered by a viral illness (think URI 1-2 weeks prior), peaks in toddlers and school-age children, and resolves spontaneously in the majority of cases within weeks to months — often without any treatment. Adult ITP has a different natural history: it's more insidious, not post-viral, more commonly affects women of reproductive age, and follows a chronic relapsing course requiring stepwise immunosuppression (steroids → IVIG → rituximab → splenectomy). Conflating these means you'll mismanage the vignette.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Identify the specific antibody target (anti-GPIIb/IIIa), where platelet destruction occurs (spleen), and which secondary conditions like SLE, HIV, and hepatitis C can cause ITP and must be ruled out before diagnosing primary ITP.
Recognize the classic ITP presentation as isolated thrombocytopenia with normal PT, PTT, and fibrinogen — and know that bleeding is mucocutaneous (petechiae, purpura, gingival) rather than deep-tissue, because platelet plug formation is impaired but clotting factors are fine.
Understand that ITP is a diagnosis of exclusion — you must rule out TTP, DIC, drug-induced thrombocytopenia, and secondary causes (HIV, HCV, SLE) before landing on primary ITP, and know what findings distinguish each mimic.
Apply stepwise management: first-line steroids ± IVIG for adults, observation vs steroids for pediatric cases, and reserve platelet transfusion for life-threatening bleeding only — not routine low counts.

Can you avoid these mistakes?

A 6-year-old boy presents with sudden onset of petechiae and gingival bleeding 2 weeks after a URI. CBC shows platelets of 15,000/µL; PT, PTT, and fibrinogen are normal. What is the most likely diagnosis, and what is the most appropriate next step in management?

A 28-year-old woman is found to have a platelet count of 18,000/µL with normal PT and PTT. Her peripheral smear shows no schistocytes. The ER team wants to transfuse platelets. Why is this not the appropriate first step, and what should be done instead?

You are evaluating a 35-year-old man with isolated thrombocytopenia (platelets 22,000/µL) and normal coagulation studies. What infectious and autoimmune conditions must be excluded before diagnosing primary ITP, and why does this distinction affect management?

A patient with ITP has a platelet count of 8,000/µL and is started on prednisone. Compare the expected natural history and long-term management strategy if this patient were a 5-year-old child versus a 45-year-old adult.

Immune Thrombocytopenic Purpura (ITP)

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics